Although previous studies have demonstrated that curcumin treatment modulates the levels and transcription activity of AR [43]–[45], the activation of PKD1 by curcumin and the inhibition of β-catenin activity might be another mechanism for the regulation of AR function and prostate cancer growth. This evidence concerns the gene PKD1 and Familial prostate cancer.